Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 1.042T	--
Jan 30, 2025	2025/Q3	-- / 1.132T	--
Oct 31, 2024	2025/Q2	1.176T / 1.079T	--
Jul 31, 2024	2025/Q1	1.208T / 1.081T	--
May 9, 2024	2024/Q4	1.051T / 899.902B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 1.042T--

Jan 30, 20252025/Q3-- / 1.132T--

Oct 31, 20242025/Q21.176T / 1.079T--

Jul 31, 20242025/Q11.208T / 1.081T--

May 9, 20242024/Q41.051T / 899.902B--

Unlock Free Earnings Estimates

Open Account

Takeda Pharmaceutical Earnings Reports

6-K: Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

Dec 13 06:16 ET

6-K: Semi-annual Securities Report

Oct 31 06:31 ET

6-K: Earnings Report for the Six-month Period Ended September 30, 2024

Oct 31 06:26 ET

6-K: Notice of the Revised Forecast of Consolidated Financials for FY2024

Oct 31 06:21 ET

Trending US Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

DMZPY

+3.16%